Advanced search
Publication Cover
Journal of Dermatological Treatment Volume 34, 2023 - Issue 1
Submit an article Journal homepage
5,256
Views
0
CrossRef citations to date
0
Altmetric
Case Report

Successful treatment of rare linear lichen planopilaris with Ixekizumab

Hanof Ahmeda Department of Dermatology & Venereology, Hamad Medical Corporation, Doha, Qatar;b Translational Research Institute, Hamad Medical Corporation, Doha, QatarORCID Iconhttps://orcid.org/0000-0001-5152-2640View further author information
ORCID Icon,
Mahir Petkarc Department of Pathology, Hamad Medical Corporation, Doha, QatarORCID Iconhttps://orcid.org/0000-0002-0297-8075View further author information
ORCID Icon &
Martin Steinhoffa Department of Dermatology & Venereology, Hamad Medical Corporation, Doha, Qatar;b Translational Research Institute, Hamad Medical Corporation, Doha, Qatar;d Department of Dermatology, Weill Cornell Medicine, New York, NY, USA;e School of Medicine, Weill Cornell Medicine-Qatar, Doha, Qatar;f School of Medicine, Qatar University, Doha, QatarCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-7090-2187View further author information
ORCID Icon
Article: 2201364 | Received 22 Feb 2023, Accepted 05 Apr 2023, Published online: 02 May 2023

References

  • Bolduc C, Sperling LC, Shapiro J. Primary cicatricial alopecia: lymphocytic primary cicatricial alopecias, including chronic cutaneous lupus erythematosus, lichen planopilaris, frontal fibrosing alopecia, and Graham-Little syndrome. J Am Acad Dermatol. 2016;75(6):1–4.
  • Ross EK, Tan E, Shapiro J. Update on primary cicatricial alopecias [published correction appears in J Am Acad Dermatol. 2005 Sep;53(3):496]. J Am Acad Dermatol. 2005;53(1):1–40.
  • Tursen U, Api H, Kaya T, et al. Treatment of lichen planopilaris with mycophenolate mofetil. Dermatol Online J. 2004;10(1):24.
  • Cevasco NC, Bergfeld WF, Remzi BK, et al. A case-series of 29 patients with lichen planopilaris: the Cleveland Clinic Foundation experience on evaluation, diagnosis, and treatment. J Am Acad Dermatol. 2007;57(1):47–53.
  • Chiang YZ, Bundy C, Griffiths CE, et al. The role of beliefs: lessons from a pilot study on illness perception, psychological distress and quality of life in patients with primary cicatricial alopecia. Br J Dermatol. 2015;172(1):130–137.
  • Trindade de Carvalho L, Meah N, Wall D, et al. Recalcitrant lichen planopilaris and frontal fibrosing alopecia responding to tildrakizumab. Dermatol Ther. 2020;33(4):e13694.
  • Alam MS, LaBelle B. Treatment of lichen planopilaris with adalimumab in a patient with hidradenitis suppurativa and rheumatoid arthritis. JAAD Case Rep. 2020;6(3):219–221.
  • Brembilla NC, Senra L, Boehncke WH. The IL-17 family of cytokines in psoriasis: IL-17A and beyond. Front Immunol. 2018;9:1682.
  • Chiang C, Sah D, Cho BK, et al. Hydroxychloroquine and lichen planopilaris: efficacy and introduction of Lichen Planopilaris Activity Index scoring system. J Am Acad Dermatol. 2010;62(3):387–392.
  • Sperling LC, Nguyen JV. Commentary: treatment of lichen planopilaris: some progress, but a long way to go. J Am Acad Dermatol. 2010;62(3):398–401.
  • Lyakhovitsky A, Amichai B, Sizopoulou C, et al. A case series of 46 patients with lichen planopilaris: demographics, clinical evaluation, and treatment experience. J Dermatolog Treat. 2015;26(3):275–279.
  • Delacerda AB, Chandler RG, Wells MJ, et al. Isolated linear lichen planopilaris: extremely rare when limited to the scalp. Cutis. 2013;92(6):303–305.
  • Kowal A, Warmińska J, Krasowska D. Immunosuppressive drugs in dermatology–benefits and threats. Ann Univ Mariae Curie Sklodowska Med. 2003;58(2):14–21.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.